Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
Patents for C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
05/2006
05/18/2006US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile
05/17/2006EP1656359A2 Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
05/11/2006US20060100164 11-N-[4-(4-Pyridin-3-yl-imidazol-1-yl)-butyl]-6-O-methyl-5-O-(3-dimethylamino-2-hydroxy-propoxy)-3-oxo-erythronolide A, 11,12-carbamate; functionalized macrolides; antiviral, antiprotozoal, anticancer and antigastrointestinal
05/04/2006WO2006047740A2 Heat shock protein 90 inhibitors
05/04/2006WO2006046123A2 Conjugates with anti-inflammatory activity
05/04/2006CA2585711A1 Conjugates with anti-inflammatory activity
04/2006
04/27/2006US20060089495 Heat shock protein 90 inhibitors
04/27/2006US20060089346 Optionally fused aryl-substituted azepanones, oxazepanone or thiazepanones substituted with a dipeptide group, e.g., N2-[(3,5-difluorophenyl)acetyl]-N1-[(2R,3R)-2-(2,5-difluorophenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl]-L-alaninamide; secretase inhibitors for treating Alzheimer's disease
04/18/2006US7030238 C-nitroso compounds and use thereof
04/13/2006WO2006037775A1 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments
04/06/2006CA2581375A1 Specific kinase inhibitors
03/2006
03/30/2006US20060069083 Pesticidal dibenzo(hetero)azepine derivatives
03/30/2006US20060069047 Antibiotic conjugates
03/30/2006CA2580250A1 Loxapine analogs and methods of use thereof
03/29/2006EP1638549A2 Novel antibacterial agents
03/23/2006US20060063753 Use of nefopam for the treatment of nausea or emesis
03/16/2006US20060058278 Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
03/15/2006EP1304326B1 Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-ona and obtaining a new form of 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a
03/09/2006US20060052362 Skeletal muscle protecting agent
03/08/2006EP1632494A1 Vasopressin v1a antagonists
03/08/2006EP1631296A1 2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease
03/08/2006EP1328527B1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents
03/07/2006US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient
03/02/2006WO2006023242A1 Benzoxazepine derivatives as selective estrogen receptor modulators
03/02/2006WO2006021213A2 Vasopressin v1a antagonists
03/02/2006CA2689274A1 Vasopressin via antagonists
03/02/2006CA2688912A1 Vasopressin v1a antagonists
03/02/2006CA2688865A1 Vasopressin v1a antagonists
03/02/2006CA2576747A1 Benzoxazepine derivatives as selective estrogen receptor modulators
03/01/2006CN1740164A 2-trifluoromethyl-4,5-dihydrobenzo [d]1-aza-3-oxa and its synthesis process
02/2006
02/23/2006US20060040917 Benzoxazepine derivatives as selective estrogen receptor modulators
02/23/2006US20060040910 Macrocycles useful in the treatment of Alzheimer's disease
02/23/2006US20060040905 Formulation of nefopam and its use in the treatment of pain
02/23/2006CA2575979A1 Novel serotonin receptor ligands and their uses thereof
02/21/2006US7001901 Tetrazolylpropionamides as inhibitors of Aβ protein production
02/08/2006EP1623710A1 Receptor antagonist
02/01/2006CN1239497C Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide
01/2006
01/26/2006WO2005077463A3 Ligand for a monoamine receptor or transporter for treating addiction or dependence
01/25/2006EP1506179B1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof
01/24/2006US6989139 Matrix metalloproteinase inhibitors
01/12/2006WO2006004841A2 Galanin agonists
01/11/2006EP1474404A4 Method for extracting a macrolide from biomatter
12/2005
12/22/2005WO2005121133A1 Highly selective novel amidation method
12/22/2005CA2569686A1 Highly selective novel amidation method
12/21/2005CN1711250A Benzoxazocines and their use as monoamine-reuptake inhibitors
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/01/2005WO2005052542A3 Method and composition useful for determining fk 506
11/2005
11/30/2005EP1600166A1 Skeletal muscle protecting agent
11/24/2005WO2005056539A3 A process for the resolution of nefopam
11/24/2005US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis
11/23/2005EP1597260A1 Triazole compounds useful in therapy
11/16/2005EP0979227B1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
11/09/2005EP1593676A1 8-Chloro-11-(4-(2'-hydroxyethyl)piperazin-1-yl)-dibenzo[b,f][1,4]oxazepine of atypical anti-psychotic activity and having a low affinity for the dopamine D2 receptor
11/09/2005CN1694876A Dibenzoxazepine
11/03/2005WO2005103019A1 Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors
11/03/2005CA2563826A1 Treatment of cns disorders using cns target modulators
11/03/2005CA2558741A1 Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors
11/02/2005EP1591120A1 Receptor agonists
10/2005
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005CN1688527A Fused benzene derivative and use
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/13/2005WO2005095366A1 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3h)-one derivatives and their use as progesterone receptor modulators
10/12/2005CN1681768A Process for production of high-purity enamines
10/06/2005US20050222121 Atypical antipsychotic agents having low affinity for the D2 receptor
10/04/2005US6951940 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
09/2005
09/29/2005US20050215539 Derivatives of 1,2,3,5-tetrahydro-1-benzazepine, and 1,2,3,5-tetrahydro-4,1-benzoxazepine, benzthiazepine, and benzodiazepine: 4-methyl-5-(5-methyl-2-oxo-5-phenyl-1,2,3,5-tetrahydro-4,1-benzoxazepin-7-yl)thiophene-2-carbonitrile; contraceptives; hormone replacement therapy; antineoplastic agents
09/28/2005EP1578198A1 Pesticidal dibenzo(hetero)azepine derivatives
09/22/2005WO2005088307A1 Immunoassays for everolimus
09/22/2005US20050208607 Immunoassays for everolimus
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/15/2005US20050203295 NO donor has a nitroso group attached to a tertiary carbon; vascular relaxants, nonsteroidal anti-inflammatory drug; water soluble; potentiated by adding glutathione, use low dosage
09/14/2005EP1572672A1 Benzoxazocines and their use as monoamine-reuptake inhibitors
09/14/2005CN1668294A Use of nefopam for the treatment of nausea or emesis
09/09/2005WO2004093796A3 Lactam derivatives and methods of their use
09/01/2005US20050192318 5-[4-Methylsulfonyloxy-2-(S)-(3,4-dichlorophenyl)butyl]-10-cyano-3-(R)-methyl-6-oxo-3,4,5,6-tetrahydro-2H-benzo[b][1,5]oxazocine as antidepressant
08/2005
08/25/2005WO2005077463A2 Ligand for a monoamine receptor or transporter for treating addiction or dependence
08/25/2005US20050187386 Drug screening for agents to treat cardiovascular disorders; use of drug JTV-519, a member of the 1,4 benzothiazepine family of compounds, to repair leak in ryanodine receptor RyR2 channels
08/18/2005DE102004004928A1 Dibenzoxazepine II Dibenzoxazepines II
08/11/2005WO2005072741A1 ((11-oxo-10,11-dihydrodibenzo [b, f] [1, 4] oxazepin-1-yl)oxy) acetic acid derivatives and related compounds as cardiovascular preparations used to treat arteriolosclerosis
08/10/2005CN1653059A Macrocyclic compounds useful as pharmaceuticals
08/10/2005CN1653054A Benzoxazine derivatives as 5-HT6 modulators and uses thereof
08/03/2005EP1558341A2 Transcription factor modulating compounds and methods of use thereof
08/03/2005CN1649852A Method for extracting a macrolide from biomatter
08/03/2005CN1213036C Novel amide derivatives
08/02/2005US6924277 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases
07/2005
07/26/2005US6921760 Psychotherapeutic agents.
07/20/2005EP1554250A1 Novel lactams and uses thereof
07/19/2005US6919328 Derivatives of dibenz(b,e)-1,4-diazepine, dibenz(b,f)-1,4-oxazepine or dibenz(b,e)-1,4-thiazepine as enzyme inhibitors of the nitric oxide synthase (NOS) isoforms synthesized in neuronal cells and macrophages; stroke
07/14/2005WO2005040142B1 Novel keto-oxadiazole derivatives as cathepsin inhibitors
07/13/2005EP1553077A1 Process for production of high-purity enamines
07/13/2005EP1553074A1 Fused benzene derivative and use
07/13/2005CN1636597A Compounds for the treatment of female sexual dysfunction
07/12/2005CA2094335C 4,1-benzoxazepin derivatives and their use
06/2005
06/30/2005US20050143576 Process for production of high-purity enamines
06/23/2005WO2005056539A2 A process for the resolution of nefopam
06/23/2005CA2548507A1 A process for the resolution of nefopam
06/22/2005CN1207288C Retroviral protease inhibiting compounds
06/16/2005US20050130962 Seratonin receptor antagonist; central nervous system disorders; halo phenyl substituents
06/15/2005EP1539721A1 Dibenzoxazepine
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 21